Bradley Glover
Geschäftsführer bei IMUGENE LIMITED
Vermögen: 107 815 $ am 30.04.2024
Aktive Positionen von Bradley Glover
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IMUGENE LIMITED | Geschäftsführer | 21.08.2023 | - |
Karriereverlauf von Bradley Glover
Ehemalige bekannte Positionen von Bradley Glover
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CELULARITY INC. | Geschäftsführer | 04.10.2022 | 31.05.2023 |
| Technik-/Wissenschafts-/F&E-Leiter | 16.07.2021 | 04.10.2022 | |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2021 | - |
| KITE PHARMA INC | Corporate Officer/Principal | 01.09.2016 | - |
Ausbildung von Bradley Glover
| The University of Colorado | Doctorate Degree |
| Rady School of Management at UC San Diego | Masters Business Admin |
| University of California San Diego | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Australien | 2 |
Operativ
| Chief Operating Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Consumer Services | 4 |
| Commercial Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CELULARITY INC. | Commercial Services |
| IMUGENE LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Celularity, Inc. (United States)
Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Commercial Services |
- Börse
- Insiders
- Bradley Glover
- Erfahrung
